Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Sunday Omilabu"'
Autor:
Akin Abayomi, Mobolanle R. Balogun, Munir Bankole, Aduragbemi Banke-Thomas, Bamidele Mutiu, John Olawepo, Morakinyo Senjobi, Oluwakemi Odukoya, Lanre Aladetuyi, Chioma Ejekam, Akinsanya Folarin, Madonna Emmanuel, Funke Amodu, Adesoji Ologun, Abosede Olusanya, Moses Bakare, Abiodun Alabi, Ismail Abdus-Salam, Eniola Erinosho, Abimbola Bowale, Sunday Omilabu, Babatunde Saka, Akin Osibogun, Ololade Wright, Jide Idris, Folasade Ogunsola
Publikováno v:
Globalization and Health, Vol 17, Iss 1, Pp 1-10 (2021)
Abstract Background Lagos state is the industrial nerve centre of Nigeria and was the epicentre of the 2014 Ebola outbreak in Nigeria as it is now for the current Coronavirus Disease (COVID-19) outbreak. This paper describes how the lessons learned f
Externí odkaz:
https://doaj.org/article/d43bd89d178a490da6a03a361d892395
Autor:
Hong Quan, Uche Igbasi, Wellington Oyibo, Sunday Omilabu, Shen-Bo Chen, Hai-Mo Shen, Chukwuma Okolie, Jun-Hu Chen, Xiao-Nong Zhou
Publikováno v:
Infectious Diseases of Poverty, Vol 9, Iss 1, Pp 1-11 (2020)
Abstract Background Plasmodium falciparum-resistance to sulphadoxine-pyrimethamine (SP) has been largely reported among pregnant women. However, the profile of resistance markers to SP dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps
Externí odkaz:
https://doaj.org/article/52795ab5028444ae9fab6dee63d385b4
Autor:
Chikwe Ihekweazu, Charles Akataobi Michael, Patrick M. Nguku, Ndadilnasiya Endie Waziri, Abdulrazaq Garba Habib, Mathew Muturi, Abayomi Olufemi, Asabe A. Dzikwi-Emennaa, Muhammad Shakir Balogun, Tyakaray Ibrahim Visa, Mahmood Muazu Dalhat, Nnomzie Charles Atama, Chukwuma David Umeokonkwo, Gideon Mbrusa Mshelbwala, Columba Teru Vakuru, Junaidu Kabir, Emmanuel C. Okolocha, Jarlath U. Umoh, Babasola Olugasa, Olutayo Babalobi, Lami Lombin, Simeon Cadmus, Kaitlin Sandhaus, Philip M. Ricks, Albert Ogunkoya, Sola Aruna, Aisha Abubakar, Yusuf Bidemi, Kariuki Njenga, Garba Ibrahim, Olukemi Adekanmbi, Ifeoma Nwadiuto, Idris S. Hadejia, Gatai Nganda, Kwaga Jacob, Olajide Owolodun, Okafor Christoper, T.Z. Gandi Benjamin Tule, Habib Abdulrazak, Dooshima Kwange, Sabitu Kabiru, Gidado M. Muhammed, Tony Joannis, Sunday Omilabu, Junaid Kabir, G.A.T. Ogundipe, Olubunmi Ojo, Obasanya Joshua, Aisha Abubakar Sadiq, Olayinka Adebola, Abdullahi A. Magaji, Aisha Nasir, Dan Duvall, S. Tekki, Sati Ngulukun, Dotun Soruuke, Abiodun Egumenu, Ibro Idiona, Oyiri Ferdinand, Olufemi Abayomi, Ilori Elsie, Visa I. Tyakaray, Angela Oyo-Ita, Godson Ana, Olaniran Alabi, Mabel Aworh, John Kvagai, Gana Chinyere, Okara Gloria
Publikováno v:
One Health, Vol 13, Iss , Pp 100257- (2021)
Nigeria, with a population of over 190 million people, is rated among the 10 countries with the highest burden of infectious and zoonotic diseases globally. In Nigeria, there exist a sub-optimal surveillance system to monitor and track priority zoono
Externí odkaz:
https://doaj.org/article/56a7262d2d2c475ca2df45ff0a47cd74
Autor:
Chika Kingsley Onwuamah, Azuka Patrick Okwuraiwe, Olumuyiwa B Salu, Joseph O Shaibu, Nnaemeka Ndodo, Samuel O Amoo, Leona C Okoli, Fehintola A Ige, Rahaman A Ahmed, Munir Akinwale Bankole, Judith O Sokei, Bamidele Paul Mutiu, James Ayorinde, Babatunde Akeem Saka, Celestina Obiekea, Nwando Mba, Richard A Adegbola, Sunday Omilabu, Chikwe Ihekweazu, Babatunde Lawal Salako, Rosemary Audu
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246637 (2021)
A key element in containing the spread of the SARS-CoV-2 infection is quality diagnostics which is affected by several factors. We now report the comparative performance of five real-time diagnostic assays. Nasopharyngeal swab samples were obtained f
Externí odkaz:
https://doaj.org/article/6bd2628e3bab4697bc90b1209967e43c
Autor:
Christian Chigozie Makwe, Kehinde Sharafadeen Okunade, Muyiwa Kayode Rotimi, Oluwayemisi Esther Ekor, Olalekan Gabriel Oyeleke, Qazeem Oladele Bello, Ayodeji Ayotunde Oluwole, Iorhen Ephraim Akase, Beatrice Nkoli Ezenwa, Iretiola Bamikeolu Fajolu, Rotimi Williams Dada, Yewande Oshodi, John Olutola Olatosi, Olabisi Oluranti Opanuga, Sunday Omilabu, Veronica Chinyere Ezeaka, Bosede Bukola Afolabi
Publikováno v:
The Pan African Medical Journal, Vol 36, Iss 100 (2020)
The COVID-19 pandemic is currently causing widespread infection and deaths around the world. Since the identification of the first case in Nigeria in February 2020, the number of confirmed cases has risen to over 9,800. Although pregnant women are no
Externí odkaz:
https://doaj.org/article/5e236d013f5f4214a44279ebe5f147ce
Autor:
Emmanuel Jolaoluwa Awosanya, Gabriel Ogundipe, Olutayo Babalobi, Sunday Omilabu, Patrick Nguku
Publikováno v:
The Pan African Medical Journal, Vol 16, Iss 102 (2013)
INTRODUCTION:Worldwide, three Influenza-A virus subtypes (i.e., H1N1, H1N2 and H3N2) in swine are of major public health importance because of involvement in Influenza pandemics. In Nigeria, the existence of these subtypes in pigs has not been well s
Externí odkaz:
https://doaj.org/article/c00070e4378e40a6b4496de8f841538a
Autor:
A O Oyefolu, AbdulAzeez A. Anjorin, O.B. Salu, Oluwaseyi Sedowhe Ashaka, Sunday Omilabu, B.O. Oke, Mercy Remilekun Orenolu, Ayorinde Babatunde James
Publikováno v:
African Health Sciences
Background: Parvovirus B19 (B19) has tropism for cells of the erythroid lineage, which may lead to transient inhibition of erythropoiesis. Several studies and case reports suggested that B19 infection may contribute significantly to severe chronic an
Autor:
Anyebe Onoja, Temitope Faleye, Johnson Adeniji, Rosemary Audu, Sunday Omilabu, Babayunde Salako
Publikováno v:
Proceedings of the Nigerian Academy of Science.
Since 1985, there has been resurgence of yellow fever in Africa with outbreaks occurring in more than 33 countries. From that time, thousands of cases have occurred in Nigeria which is the most populous country in Africa. Semi-urban and urban centres
Autor:
Adesoji O Ademuyiwa, Erere Otrofanowei, Wasiu Lanre Adeyemo, O.B. Salu, Felix M Alakaloko, Iorhen E. Akase, A. A. Ajayi, Olufemi Emmanuel Babalola, Christopher O Bode, Sunday Omilabu
IntroductionIn vitro studies have shown the efficacy of Ivermectin (IV) to inhibit the SARS - CoV-2 viral replication, but questions remained as to In-vivo applications. We set out to explore the efficacy and safety of Ivermectin in persons infected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a3b5cbd1a59dabd0741df7fc7020912
https://doi.org/10.1101/2021.01.05.21249131
https://doi.org/10.1101/2021.01.05.21249131
Autor:
Chinyere Ezeaka, Roosevelt Anyanwu, Sunday Omilabu, Olabisi Opanuga, Nelson Daniel, Sulaimon Akanmu, Beatrice Nkolika Ezenwa, Bosede B Afolabi, Gabriel Oyeleke, Christian Chigozie Makwe, Titilope A Adeyemo, Kehinde S Okunade, J O Olatosi, Muyiwa Kayode Rotimi, Ayodeji A. Oluwole, Rotimi Williams Dada, Iretiola Bamikeolu Fajolu, Yewande O. Oshodi, O.B. Salu, Iorhen E. Akase
Publikováno v:
PAMJ Clinical Medicine. 5
INTRODUCTION: COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa.